If all goes well, India may get first Covid-19 vaccine by February

AstraZeneca vaccine is likely to cost Rs 500-600 per dose in the private market

Coronavirus, vaccine, covid, drugs, clinical trials
Industry sources further indicated that data from AstraZeneca’s large-scale UK trials would be ready by December and after that it could be submitted to the Indian regulator

If all goes well, India may get its first vaccine for Covid-19 around February 2021. According to sources, the country’s drug regulator is likely to issue an emergency use authorisation (EUA) to at least one vaccine candidate by the end of January. This would be procured by the government to vaccinate those on the priority list, that is, frontline health workers and the vulnerable population. “The NITI Aayog, members of the Central Drugs Standard Control Organisation (CDSCO) and the Indian Council of Medical Research (ICMR) are keeping a real-time watch on the clinical ...